These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8650039)
21. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943 [TBL] [Abstract][Full Text] [Related]
22. [Visceral mycotic infections. In clinical practice]. André MH; Lortholary O Rev Prat; 2001 Apr; 51(7):758-60. PubMed ID: 11387673 [No Abstract] [Full Text] [Related]
23. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356 [TBL] [Abstract][Full Text] [Related]
24. [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole]. Manabe A; Ebihara Y; Saito A; Takahashi K; Hosoya R Rinsho Ketsueki; 1997 Aug; 38(8):669-73. PubMed ID: 9311273 [TBL] [Abstract][Full Text] [Related]
25. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group. Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812 [TBL] [Abstract][Full Text] [Related]
26. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280 [TBL] [Abstract][Full Text] [Related]
27. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation]. Burgaleta C Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303 [No Abstract] [Full Text] [Related]
28. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial. Timmers GJ; Zweegman S; Simoons-Smit AM; van Loenen AC; Touw D; Huijgens PC Bone Marrow Transplant; 2000 Apr; 25(8):879-84. PubMed ID: 10808210 [TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845 [TBL] [Abstract][Full Text] [Related]
30. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448 [TBL] [Abstract][Full Text] [Related]
32. [Emergency of fluconazole-resistant infections by Candida krusei and Candida glabrata in neutropenic patients]. Piemonte P; Conte G; Flores C; Barahona O; Araos D; Alfaro J; Fardella P; Thompson L Rev Med Chil; 1996 Sep; 124(9):1149. PubMed ID: 9197032 [No Abstract] [Full Text] [Related]
33. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing? Isaacs D Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea. Sohn HS; Lee TJ; Kim J; Kim D Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases]. Candoni A; Russo D; Salmaso F Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834 [TBL] [Abstract][Full Text] [Related]
36. [Prevention of mycotic infections in liver transplant recipients: comparison of two chemoprophylactic protocols]. Biancofiore G; Baldassarri R; Bindi ML; Mosca C; Filipponi F; Mosca F; Vagelli A Minerva Anestesiol; 2001 Jun; 67(6):475-82. PubMed ID: 11533546 [TBL] [Abstract][Full Text] [Related]
37. Fluconazole in children: first experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer. Cáp J; Mojzesova A; Kayserova E; Bubánska E; Hatiar K; Trupl J; Krcméry V Chemotherapy; 1993; 39(6):438-42. PubMed ID: 8222873 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic use of fluconazole in neutropenic cancer patients. Yamaç K; Senol E; Haznedar R Postgrad Med J; 1995 May; 71(835):284-6. PubMed ID: 7596933 [TBL] [Abstract][Full Text] [Related]
39. [Incidence of fungal infection in surgical diseases of the pancreas]. Szendrényi V; Farkas G; Karácsonyi S; Nagy E Orv Hetil; 1991 Nov; 132(45):2487-92. PubMed ID: 1945393 [TBL] [Abstract][Full Text] [Related]
40. [Is it possible to prevent mycotic infections in oncology patients?]. Mayer J; Vorlícek J Vnitr Lek; 1994 Dec; 40(12):783-8. PubMed ID: 7839633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]